AI assistant
Sending…
iBio, Inc. — Director's Dealing 2025
Nov 24, 2025
35045_dirs_2025-11-24_4188b09c-9a58-4dec-ae15-f829cb4a7d69.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2025-11-20
Reporting Person: Parada Antonio Bernardino Guimaraes (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | Stock Option (right to buy) | $1.00 | A | 13500 | Acquired | 2035-11-19 | Common Stock (13500) | Direct |
Footnotes
F1: These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.
More from iBio, Inc.
Regulatory Filings
2026
Jul 1
Call Transcript
2026
Jun 4
Capital/Financing Update
2026
Apr 29
Call Transcript
2026
Apr 8
Regulatory Filings
2026
Apr 8
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23
Call Transcript
2026
Mar 17
Call Transcript
2026
Mar 9
Capital/Financing Update
2026
Feb 27